Mycophenolate mofetil Completed Phase 2 Trials for Stage IV Adult Diffuse Large Cell Lymphoma / Childhood Immunoblastic Lymphoma / Stage II Adult Non-Contiguous Immunoblastic Lymphoma / Stage IV Childhood Anaplastic Large Cell Lymphoma / Stage III Grade 2 Follicular Lymphoma / Secondary Myelodysplastic Syndromes / Recurrent Adult Diffuse Large Cell Lymphoma / Recurrent Mantle Cell Lymphoma / Childhood Acute Lymphoblastic Leukemia in Remission / Stage III Adult Diffuse Large Cell Lymphoma / Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma / Stage I Childhood Burkitt Lymphoma / Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma / Stage I Grade 2 Follicular Lymphoma / Stage IV Adult Diffuse Small Cleaved Cell Lymphoma / Stage IV Childhood Large Cell Lymphoma / Stage III Adult Burkitt Lymphoma / Recurrent Childhood Large Cell Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Stage II Non-Contiguous Adult Burkitt Lymphoma / Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3- / Stage IV Marginal Zone Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Stage III Childhood Anaplastic Large Cell Lymphoma / Stage II Grade 2 Non-Contiguous Follicular Lymphoma / Stage III Childhood Lymphoblastic Lymphoma / Childhood Acute Myeloid Leukemia in Remission / Stage IV Grade 1 Follicular Lymphoma / Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma / Stage I Adult Diffuse Large Cell Lymphoma / Recurrent Marginal Zone Lymphoma / Refractory Plasma Cell Myeloma / Stage I Adult Burkitt Lymphoma / Recurrent Adult Immunoblastic Lymphoma / Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Stage II Non-Contiguous Mantle Cell Lymphoma / Stage II Grade 3 Non-Contiguous Follicular Lymphoma / Stage II Grade 1 Non-Contiguous Follicular Lymphoma / Stage III Adult Lymphoblastic Lymphoma / Recurrent Adult Burkitt Lymphoma / Stage II Small Lymphocytic Lymphoma / Stage I Adult Immunoblastic Lymphoma / Stage II Contiguous Adult Diffuse Large Cell Lymphoma / Stage II Grade 3 Contiguous Follicular Lymphoma / Stage IV Childhood Lymphoblastic Lymphoma / Stage II Grade 2 Contiguous Follicular Lymphoma / Previously Treated Myelodysplastic Syndromes / Stage III Adult Diffuse Small Cleaved Cell Lymphoma / Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL / Recurrent Grade 3 Follicular Lymphoma / Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative / Stage III Adult Immunoblastic Lymphoma / Stage II Contiguous Adult Lymphoblastic Lymphoma / Stage I Mantle Cell Lymphoma / Stage IV Adult Diffuse Mixed Cell Lymphoma / Stage II Childhood Anaplastic Large Cell Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Stage III Grade 1 Follicular Lymphoma / Recurrent Childhood Burkitt Lymphoma / Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable / Childhood Diffuse Large Cell Lymphoma / Stage IV Mantle Cell Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Stage I Childhood Large Cell Lymphoma / Stage I Childhood Lymphoblastic Lymphoma / Stage IV Adult Lymphoblastic Lymphoma / Recurrent Childhood Anaplastic Large Cell Lymphoma / Stage II Contiguous Adult Burkitt Lymphoma / Recurrent Adult Acute Myeloid Leukemia / Stage I Grade 1 Follicular Lymphoma / Adult Acute Myeloid Leukemia in Remission / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Stage III Mantle Cell Lymphoma / Stage II Childhood Burkitt Lymphoma / Stage III Childhood Large Cell Lymphoma / Childhood Myelodysplastic Syndrome / Stage IV Childhood Burkitt Lymphoma / Stage III Childhood Burkitt Lymphoma / Waldenström's Macroglobulinemia (WM) / Chronic Lymphocytic Leukemia (CLL) - Refractory / Recurrent Adult Acute Lymphoblastic Leukemia / Stage III Grade 3 Follicular Lymphoma / Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 / Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 / Stage I Grade 3 Follicular Lymphoma / Stage I Adult Lymphoblastic Lymphoma / Stage I Childhood Anaplastic Large Cell Lymphoma / Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Childhood Burkitt Lymphoma / Stage IV Grade 2 Follicular Lymphoma / Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Stage IV Adult Burkitt Lymphoma / Stage II Childhood Lymphoblastic Lymphoma / Stage I Adult Diffuse Mixed Cell Lymphoma / Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA / Recurrent Small Lymphocytic Lymphoma / Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma / Recurrent Childhood Acute Lymphoblastic Leukemia / Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma / Stage II Contiguous Mantle Cell Lymphoma / Stage IV Adult Immunoblastic Lymphoma / Stage III Marginal Zone Lymphoma / Stage II Grade 1 Contiguous Follicular Lymphoma / Stage IV Grade 3 Follicular Lymphoma / Recurrent Childhood Hodgkin Lymphoma / Recurrent Childhood Acute Myeloid Leukemia / Stage I Small Lymphocytic Lymphoma / Recurrent Childhood Lymphoblastic Lymphoma / Adult Acute Lymphoblastic Leukemia in Remission / Stage III Adult Diffuse Mixed Cell Lymphoma / Stage II Adult Contiguous Immunoblastic Lymphoma / Stage III Small Lymphocytic Lymphoma / Stage IV Small Lymphocytic Lymphoma / Stage II Non-Contiguous Adult Lymphoblastic Lymphoma / Stage I Marginal Zone Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00105001Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
NCT00031655Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission